Delivery Order SPE2DB22D3009-SPE2DB25FBA18
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,531.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azstarys 26.1 mg–5.2 mg capsules (100 count). This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,782.29 to AmerisourceBergen Drug Corp for AZSTARYS 39.2 mg-7.8 mg capsules (100-count) on August 19, 2025, with completion scheduled for August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle...
- This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,856.69 to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on August 20, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is issued under AmerisourceBergen's larger...
- This is a $1,304.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a performance period ending on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,277.09, is for the provision of AZSTARYS CAPS 52.3MG/10.4MG, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azstarys 39.2 mg-7.8 mg capsules (100-count packaging) with a ceiling value of $1,436.84. This competitively awarded, non-set-aside delivery order represents a firm fixed-price contract with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,284.14, is for the delivery of AZSTARYS CAPS 39.2MG/7.8MG, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 12, 2025. The contract has no set-aside designation, indicating open...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $2,959.88 contract is for the delivery of the medication AZSTARYS CAPS 39.2MG/7.8MG. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026. This IDC serves as a comprehensive global...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,848.20 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for AZSTARYS capsules (39.2mg/7.8mg), a prescription medication used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed price, non-set-aside contract is scheduled for completion by September 12, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single...